ADVERTISEMENT



Google       

Home -> Law Blog Directory -> Copyright Law Blogs -> Michael Geist

OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense

Find a Local Lawyer

Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402

Bookmark

Copyright Law

: Michael Geist

Submissions on Canada-EU Trade Deal: Canadian Generic Pharma Assoc. Wants IP Out

By Michael Geist

ADVERTISEMENTS
Continuing the review of submissions to DFAIT regarding the Canada-EU Trade Agreement, the Canadian Generic Pharmaceutical Association warned against the inclusion of any intellectual property provisions:

The very fact that both Canada and EU have robust IP systems in place should be a sufficient basis on which to enhance and expand our existing trade relationship. The Government of Canada has an obligation to ensure an economic agreement with the European Union will not harm domestic industries and will not disadvantage Canadian companies who export products to the United States and other countries. As such, it is the view of Canada's generic pharmaceutical industry that intellectual property should not be included in any economic negotiations between Canada and the European Union - particularly as the IP measures pertain to pharmaceuticals.

Full post as published by Michael Geist on January 20, 2010 (boomark / email).

Bloggers, promote your law blog by nominating your blog for inclusion in USLaw.com's Law Blog Directory and RSS Reader. Benefits described.
Related Law Articles

Trade Secrets
Former execs are hit with doctrine of inevitable disclosure.

Lawsuits and Settlements

Canadian Government
allegedly used Canadian soldier as test subjects for nuclear explosion radiation exposure.

Medical Records
To Stay out of Pharma's Hands

Hurricane Claims
State Farm Fire and Casualty Co. reaches settlement deal with Mississippi Attorney General Jim Hood.

ETHEX Corp
5 Generic Drugs Recalled Due to Risk of Death From Overdose

Trade Secrets
Razorsight agreed to pay $4.5 million settlement in infringement lawsuit.

Generic Versions
Barr Pharmaceuticals to pay $5.9 million settlement for blocking the sale of oral contraceptives.

Related Searches

























































































































US Law
#1 Online Legal Resource













Your Blog Subscriptions
Subscribe to blogs

10,000+ Law Job Listings
Lawyer . Police . Paralegal . Etc
Earn a law-related degree
Are you the author of this blog? Adding USLaw.com to your Blogroll increases relevance. You qualify to display a USLaw Network badge.
Suggest changes to this blog's description or nominate another for inclusion. Register for updates.


Practice Area
Zip Code:

Contact a Lawyer Now!






0.015 secs (new cache)